These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8576646)

  • 1. Cellular cysteine generation does not contribute to the initiation of LDL oxidation.
    Santanam N; Parthasarathy S
    J Lipid Res; 1995 Oct; 36(10):2203-11. PubMed ID: 8576646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanisms.
    Heinecke JW; Kawamura M; Suzuki L; Chait A
    J Lipid Res; 1993 Dec; 34(12):2051-61. PubMed ID: 8301226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation of low density lipoprotein by iron or copper at acidic pH.
    Morgan J; Leake DS
    J Lipid Res; 1995 Dec; 36(12):2504-12. PubMed ID: 8847477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms by which cysteine can inhibit or promote the oxidation of low density lipoprotein by copper.
    Patterson RA; Lamb DJ; Leake DS
    Atherosclerosis; 2003 Jul; 169(1):87-94. PubMed ID: 12860254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant activity of thiocholesterol on copper-induced oxidation of low-density lipoprotein.
    Tanaka M; Nakagawa M
    Lipids; 1995 Apr; 30(4):321-5. PubMed ID: 7609599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice.
    Maor I; Hayek T; Coleman R; Aviram M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2995-3005. PubMed ID: 9409286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein.
    Parthasarathy S; Barnett J; Fong LG
    Biochim Biophys Acta; 1990 May; 1044(2):275-83. PubMed ID: 2344447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL: in vitro and in vivo studies.
    Rosenblat M; Aviram M
    Free Radic Biol Med; 1998 Jan; 24(2):305-17. PubMed ID: 9433906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human serum, cysteine and histidine inhibit the oxidation of low density lipoprotein less at acidic pH.
    Patterson RA; Leake DS
    FEBS Lett; 1998 Sep; 434(3):317-21. PubMed ID: 9742946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of copper reduction by alpha-tocopherol in low-density lipoprotein oxidation.
    Proudfoot JM; Croft KD; Puddey IB; Beilin LJ
    Free Radic Biol Med; 1997; 23(5):720-8. PubMed ID: 9296448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions.
    Retsky KL; Freeman MW; Frei B
    J Biol Chem; 1993 Jan; 268(2):1304-9. PubMed ID: 8419332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human (THP-1) macrophages oxidize LDL by a thiol-dependent mechanism.
    Graham A; Wood JL; O'Leary VJ; Stone D
    Free Radic Res; 1996 Aug; 25(2):181-92. PubMed ID: 8885336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human (THP-1) macrophages oxidize LDL by a thiol-dependent mechanism.
    Graham A; Wood JL; O'Leary VJ; Stone D
    Free Radic Res; 1994 Oct; 21(5):295-308. PubMed ID: 7842139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
    Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B
    Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein.
    Lynch SM; Frei B
    Biochim Biophys Acta; 1997 Apr; 1345(2):215-21. PubMed ID: 9106501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cu(I) availability paradoxically antagonizes antioxidant consumption and lipid peroxidation during the initiation phase of copper-induced LDL oxidation.
    Bagnati M; Bordone R; Perugini C; Cau C; Albano E; Bellomo G
    Biochem Biophys Res Commun; 1998 Dec; 253(2):235-40. PubMed ID: 9878521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies.
    Aviram M; Dankner G; Cogan U; Hochgraf E; Brook JG
    Metabolism; 1992 Mar; 41(3):229-35. PubMed ID: 1542259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human macrophages limit oxidation products in low density lipoprotein.
    Hultén LM; Ullström C; Krettek A; van Reyk D; Marklund SL; Dahlgren C; Wiklund O
    Lipids Health Dis; 2005 Mar; 4():6. PubMed ID: 15745457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural aspects of the inhibitory effect of glabridin on LDL oxidation.
    Belinky PA; Aviram M; Mahmood S; Vaya J
    Free Radic Biol Med; 1998 Jun; 24(9):1419-29. PubMed ID: 9641259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation.
    Neuzil J; Stocker R
    J Biol Chem; 1994 Jun; 269(24):16712-9. PubMed ID: 8206992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.